A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safetyof Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy

Project: Research project

Project Details

Description

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Intravenously Administered BIIB092 in Participants with Progressive Supranuclear Palsy
StatusActive
Effective start/end date4/1/182/28/21

Funding

  • BIOGEN INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.